logo

For the Inventor, By the Inventor

Dallas, TX, United States of America

Dart Neuroscience, LLC


USPTO Granted Patents = 16

% Expired Patents = 6.3



Trademarks = 4

Forward Citations = 26

Loading Chart...
Loading Chart...

38 inventors (with patents filed for the assignee):

goldMedal Laurent Gomez (6 out of 31 patents)

silverMedal Brett C Bookser (5 out of 22 patents)

bronzeMedal Joe Anh Tran (4 out of 12 patents)

4.  DeMichael Chung (4 out of 5 patents)

5.  Jillian Basinger Thompson (3 out of 3 patents)

6.  Scott Burley (3 out of 3 patents)

7.  Pablo Garcia-Reynaga (3 out of 10 patents)

8.  Benjamin Pratt (3 out of 15 patents)

9.  Aaron Thompson (3 out of 3 patents)

10.  Margaret McCarrick (3 out of 6 patents)

11.  William Vernier (3 out of 8 patents)

12.  Marco Peters (3 out of 11 patents)

13.  Michael I Weinhouse (3 out of 12 patents)

14.  Lino J Valdez (2 out of 14 patents)

15.  Robert Huerta Lemus (2 out of 19 patents)


16 patents:

1. 12715875 - Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors (2026-08-25),
2. 12643888 - Substituted cyclohexyl compounds as NOP inhibitors (2026-06-02),
3. 12630556 - Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors (2026-05-19),
4. 12319702 - Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors (2025-06-03),
5. 12006325 - Substituted furanopyrimidine compounds as PDE1 inhibitors (2024-06-11),
6. 11999738 - Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors (2024-06-04),
7. 11945808 - Substituted cyclohexyl compounds as NOP inhibitors (2024-04-02),
8. 11685745 - Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors (2023-06-27),
9. 11434247 - Substituted furanopyrimidine compounds as PDE1 inhibitors (2022-09-06),
10. 11365191 - Substituted cyclohexyl compounds as NOP inhibiiors (2022-06-21),
11. 11279691 - Substituted pyridine and pyrazine compounds as PDE4 inhibitors (2022-03-22),
12. 10981916 - Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors (2021-04-20),
13. 10738018 - Compounds for therapeutic use (2020-08-11),
14. 9963435 - Compounds for therapeutic use (2018-05-08),
15. 9241925 - Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit (2016-01-26),
Company Overview
Dart Neuroscience, LLC, based in Dallas, TX, specializes in the development of innovative therapies targeting neurological and psychiatric disorders. The company focuses on advancing drug discovery and development through its proprietary technologies, which aim to address unmet medical needs in the field of neuroscience. Dart Neuroscience is committed to leveraging its expertise to create effective treatments that improve patient outcomes and enhance the understanding of brain function and related conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#129 in Dallas, TX

#1,216 in Texas

#19,922 in US

#37,831 in the World

Dallas, TX (US)
Dallas, TX, United States of America

Dart Neuroscience, LLC

Forward Citations = 26

38 inventors:

goldMedal Laurent Gomez (6 out of 31 patents)

silverMedal Brett C Bookser (5 out of 22 patents)

bronzeMedal Joe Anh Tran (4 out of 12 patents)

4.  DeMichael Chung (4 out of 5 patents)

5.  Jillian Basinger Thompson (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dart Neuroscience, LLC. Retrieved from https://idiyas.com/company/dart-neuroscience

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…